Patients with Type I diabetes have a poorly functioning pancreas that doesn’t produce enough, or any, insulin to metabolize blood glucose. Constant and regular injections are a norm for millions suffering from the disease. But now researchers at Cornell University, working with others from Novo Nordisk and University of Michigan Medical Scho (Read more...)